ICG's pharma advertising agency delivers therapy-aware brand campaigns, visual aids, product monographs, detailing aids, objection-handling materials, and OPPI-compliant promotional creative for prescription brands in India. Built by IIT BHU pharmaceutical engineers who write from comprehension — so fewer claims get pulled by medical review.
Creative team builds the campaign. Medical review pulls 40% of the claims. The campaign that ships is the safe version — not the compelling one.
This is the structural failure of generalist advertising agencies in pharma: claims are constructed first, evidence is searched for second, citations don't materialise, medical review pulls the bold claims, the final ad is generic. ICG inverts the sequence. The evidence is read first. Claims are constructed from what the data actually supports. Citations are mapped before the creative brief is written. The result: campaigns where every claim survives medical review, because the claim was always defensible.
Brand strategy grounded in therapeutic area evidence. Promotional campaign development compliant with OPPI and Drug & Magic Remedies Act. Claims mapped to citations before any creative brief is written.
Detailing aids, product monographs, comparison charts, objection-handling tools. Every claim referenced. Designed to survive medical and legal review without a single claim being pulled.
Closed Loop Marketing modules built for 3-minute HCP visits — not 30-minute presentations.
New product launches with phased awareness, education, and trial programmes. Field force enablement integrated from Day 1.
For mature brands facing generic erosion — repositioning that defends prescription share through differentiated communication.
Detail aids, leave-behinds, congress materials, advisory board decks — produced as a coherent campaign system, not isolated assets.
ICG's Co-Founding Team and pharma practice lead are pharmaceutical engineers from IIT BHU's Department of Pharmaceutical Engineering and Technology — B.Tech and M.Tech graduates who have studied drug metabolism, formulation science, pharmacokinetics, and clinical pharmacology.
This is not a credential for a website. It is the reason why ICG manuscripts have fewer scientific errors in medical review, why ICG PSURs have fewer clarification cycles, and why the scoping call for a literature monitoring engagement sounds different from every other agency you've briefed. The science is understood before the brief is written.
ICG's commercial and field force engagements run on RxFlow, RouteIQ, Gate, Signal, and Pulse — five tools that connect field activity to prescription outcomes.
Explore the full Pharos platform →AI Scientific Writing
AI-guided manuscript development from topic selection to submission-ready output. Journal fit intelligence. CONSORT/PRISMA embedded from Day 1.
Literature Monitoring
Adverse-event-driven literature surveillance. Validated PubMed queries. De-duplication. Evidence scoring. Audit-ready search logs.
PV Resource Allocation
Risk-based drug tiering and defensible PV staffing. Objective tier from signal frequency and seriousness. Headcount you can defend with data.
Drug AE Intelligence
Single-drug adverse event visualization dashboard. On-demand data refresh. Spot signals before they escalate.
Prescription Intelligence
HCP-level prescription intelligence. Visit history, AI call analysis. See Rx switching risk before it moves.
Explore RxFlow →MR Route Optimization
AI route planning for medical representatives. Priority-scored daily call plans. Right HCP, right day, every day.
Explore RouteIQ →Sales Pipeline Intelligence
Stagnation alerts before deals go cold. Stage bottleneck heatmaps. Intervene before it's too late.
Explore Gate →MR AI Coaching
AI coaching after every HCP visit. Post-visit feedback, objection analysis. Turn each visit into a prescription.
Explore Signal →Pharma MIS Command Centre
360° commercial intelligence for leadership. Revenue, field force, distributor, market — one real-time view.
Explore Pulse →Every ICG pharma engagement runs on some combination of these nine modules. The pilot engagement determines which ones are active from Day 1.
Start a pilot project →Every ICG pharma engagement is led personally by Aditi Tripathi — M.Pharm, IIT BHU — with Abhash, Deep and Rohit (Co-Founding Team) bringing the scientific rigour, delivery architecture and commercial lens built across 8+ years. IIT BHU pharmaceutical engineers at every level of the engagement.
60+ specialists. One process. Every deliverable in-house. Gurgaon, since 2018.
Strategy Lead · IIT BHU + IIM Bangalore
Leads scientific strategy and quality governance. Sets the standard for scientific rigour across every engagement.
Profile →
Operations Lead · IIT BHU (B.Tech + M.Tech)
Owns the AI-powered delivery system — the multi-tenant operations layer that runs every pharma engagement on time and on spec.
Profile →
Business & Growth Lead · IIT BHU + IIM Rohtak
Pharma engineer who owns business growth and the commercial lens connecting science to prescription outcomes.
Profile →
IIT BHU · M.Pharm
Aditi leads every pharma engagement end to end — from scoping the scientific writing architecture to governing quality across delivery. Her M.Pharm from IIT BHU means she doesn't need the science explained to her. "She explains it to everyone else."
One deliverable. Full ICG process. Audit trail. Then you decide.
A founder will reach out within one business day. In the meantime — WhatsApp Rohit directly for the fastest reply.
💬 Message Rohit on WhatsApp
For pharma / life sciences — medical writing, scientific communications, regulatory support — I reply personally.
Message Rohit on WhatsAppOr call: +91 81302 26224